Cardiovascular safety of new oral anticoagulants: re‐analysis of 27 randomized trials based on Bayesian network meta‐analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2125|80|1|168-169

ISSN： 0306-5251

Source： BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol.80, Iss.1, 2015-07, pp. : 168-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mortality outcomes in patients receiving direct oral anticoagulants: a systematic review and meta‐analysis of randomized controlled trials

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 11, 2015-11 ,pp. : 2012-2020

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular safety of empagliflozin in patients with type 2 diabetes: a meta‐analysis of data from randomized placebo‐controlled trials

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. 10, 2016-10 ,pp. : 1034-1040

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta‐analysis of randomized trials

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1192-1200

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hormone Replacement Therapy and Secondary Cardiovascular Prevention: A Meta-Analysis of Randomized Trials

By  

Cardiology, Vol. 104, Iss. 3, 2005-09 ,pp. : 143-147

Karger

Access to resources Recommend Favorite

Phytodolor® in Musculoskeletal Disorders: Re-Analysis and Meta-Analysis

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 18, Iss. 5, 2011-10 ,pp. : 249-256

Karger

Access to resources Recommend Favorite